Ca. Sprecher et al., MOLECULAR-CLONING, EXPRESSION, AND PARTIAL CHARACTERIZATION OF A 2ND HUMAN TISSUE-FACTOR-PATHWAY INHIBITOR, Proceedings of the National Academy of Sciences of the United Statesof America, 91(8), 1994, pp. 3353-3357
Previous studies have shown that tissue-factor-pathway inhibitor (TFPI
) is an important regulator of the extrinsic pathway of blood coagulat
ion through its ability to inhibit factor Xa and factor VIIa-tissue fa
ctor activity. We describe the molecular cloning and expression of a f
ull-length cDNA that encodes a molecule, designated TFPI-2, that has a
similar overall domain organization and considerable primary amino ac
id sequence homology to TFPI. After a 22-residue signal peptide, the m
ature protein contains 213 amino acids with 18 cysteines and two canon
ical N-linked glycosylation sites. The deduced sequence of mature TFPI
-2 revealed a short acidic amino-terminal region, three tandem Kunitz-
type domains, and a carboxyl-terminal tail highly enriched in basic am
ino acids. Northern analysis indicates that TFPI-2 is transcribed in u
mbilical vein endothelial cells, liver, and placenta. TFPI-2 was expre
ssed in baby hamster kidney cells and purified from the serum-free con
ditioned medium by a combination of heparin-agarose chromatography, Mo
no Q FPLC, Mono S FPLC, and Superose 12 FPLC. Purified TFPI-2 migrated
as a single band in SDS/PAGE and exhibited a molecular mass of 32 kDa
in the presence and absence of reducing agent. The amino-terminal seq
uence of recombinant TFPI-2 was identical to that predicted from the c
DNA. Despite its structural similarity to TFPI, the purified recombina
nt TFPI-2 failed to react with polyclonal anti-TFPI IgG. Preliminary s
tudies indicated that purified recombinant TFPI-2 strongly inhibited t
he amidolytic activities of trypsin and the factor VIIa-tissue factor
complex. In addition, the inhibition of factor VIIa-tissue factor amid
olytic activity by recombinant TFPI-2 was markedly enhanced in the pre
sence of heparin. TFPI-2 at high concentrations weakly inhibited the a
midolytic activity of human factor Xa, but had no measurable effect on
the amidolytic activity of human thrombin.